Available Brands
Did you find this information helpful?
Author Details

Written By
Naina Boruah
MSc Biomedical Science

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 12 Nov 2026 | 04:45 PM (IST)

Want to know more?
Read Our Editorial Policy
Quick Summary
ALPHA KETOANALOGUE
Last updated on 12 Nov 2026 | 04:45 PM (IST)
ALPHA KETOANALOGUE
Molecule Overview
Alpha-ketoanalogues are nitrogen-free versions of essential amino acids, used alongside a very low or low protein diet to help manage chronic kidney disease (CKD) while reducing the build-up of nitrogen waste products. They belong to a category of medical nutrition therapies, most commonly known by the branded product Ketosteril. They are prescription/dietitian-guided products used specifically in pre-dialysis CKD care.
Medical Classification
Therapeutic Class: Medical nutrition therapy for chronic kidney disease (renal-specific amino acid/ketoacid supplement).
Pharmacological Class: Nitrogen-free ketoanalogues of essential amino acids.
Drug Family: Renal ketoacid/amino acid supplement therapies.
ATC Classification: V06DD (Amino acids, including combinations with polypeptides) — specific coding varies by product and region.
Conditions Treated
Approved/established use: Adjunct nutritional management of chronic kidney disease (typically CKD stages 3b-5, pre-dialysis), used alongside a low or very low protein diet to help slow disease progression while meeting essential amino acid needs without excess nitrogen intake.
Commonly used for: Metabolically stable adults with advanced CKD who are motivated and able to follow a low-protein dietary plan under close medical and dietitian supervision.
Off-label use (only under medical guidance): Not typically used off-label; use is specific to its role in structured CKD nutritional management.
Available Strengths & Dosage Forms
Oral tablets: coated tablets containing a fixed blend of calcium salts of ketoanalogues of essential amino acids (e.g., ketoisoleucine, ketoleucine, ketophenylalanine, ketovaline) plus certain amino acids (e.g., lysine, threonine, tryptophan, histidine, tyrosine).
How the Molecule Works
In advanced CKD, restricting dietary protein intake helps reduce the nitrogen waste (urea and related toxins) that the kidneys struggle to clear, which can slow disease progression. However, a very low protein diet risks providing too few essential amino acids. Alpha-ketoanalogues lack the nitrogen-containing amino group found in standard amino acids, so the body can convert them into the corresponding essential amino acid using nitrogen recycled from the body's own waste products, meeting nutritional needs without adding to the nitrogen burden.
Dosage & Administration
Standard dose: Approximately 1 tablet per 5 kg body weight per day (commonly around 9-14 tablets/day for an average adult), taken alongside a very low protein diet (0.3-0.4 g/kg/day) as directed by a nephrologist and renal dietitian.
Condition-wise dose: Some protocols use a reduced dose (e.g., 1 tablet per 10 kg/day) alongside a more moderate low-protein diet (around 0.6 g/kg/day) for patients who find the full-dose, very-low-protein regimen difficult to sustain.
Route: Oral, taken with meals, divided across the day's meals.
Missed dose: Take with the next meal as close to the regular schedule as possible; don't double up.
Overdose: Excessive intake could theoretically raise blood calcium levels, given the calcium-salt formulation; requires medical guidance if significantly exceeded.
Side Effects
Common: Generally well tolerated; mild gastrointestinal discomfort can occasionally occur.
Serious: Hypercalcemia (excess blood calcium) is a theoretical risk given the calcium-salt formulation, particularly if combined with other calcium or vitamin D supplementation without monitoring.
Emergency symptoms: Signs of hypercalcemia (nausea, confusion, excessive thirst) should prompt medical review.
Recovery advice: This therapy is specifically designed to be used under close nephrology and dietitian supervision, which allows early identification of any tolerability or calcium-related issues.
Warnings & Precautions
Pregnancy: Used only under specialist guidance, as very low protein diets in pregnancy require careful individualised management.
Breastfeeding: Used only under specialist guidance.
Liver disease: Used with caution and specialist guidance, given amino acid metabolism considerations.
Kidney disease: This is the core condition being managed; use is specifically tailored to CKD stage and nutritional status.
Elderly: Used under specialist guidance; nutritional adequacy and adherence are particularly important to assess in this age group.
Children: Used under specialist pediatric nephrology guidance if needed, with individualised dosing.
Drug Interactions
Calcium and vitamin D supplements: combined use requires monitoring of blood calcium levels, given the calcium-salt basis of this therapy.
Phosphate binders and other CKD-specific medicines: used as part of an overall CKD management plan, coordinated by the treating nephrologist rather than representing a specific interaction to avoid.
No major systemic drug-metabolism interactions have been identified, as this is a nutritional amino acid/ketoacid therapy rather than a drug metabolised through major liver enzyme pathways.
Monitoring Requirements
Kidney function tests (eGFR, creatinine) periodically to assess disease progression.
Serum albumin and nutritional status assessment, to ensure the low-protein diet plus ketoanalogue supplementation is meeting nutritional needs.
Serum calcium and phosphate levels periodically.
Dietitian follow-up to support adherence to the prescribed low-protein dietary pattern.
Alternative Molecules
Standard low-protein diet without ketoanalogue supplementation, essential amino acid supplements without the ketoanalogue modification, alternative nutritional approaches depending on the patient's specific CKD stage and needs.
Combination Therapies
Used specifically alongside a prescribed low or very low protein diet as part of a structured CKD nutritional management plan; combined with other standard CKD medical therapies (blood pressure control, phosphate management, anaemia treatment) as part of overall care, coordinated by the nephrology team.
Chronic Kidney Disease Nutritional Management
Renal Diet Supportive Therapies
Pre-Dialysis CKD Care
FAQs
Q1.
It's used alongside a low or very low protein diet to help manage chronic kidney disease, providing essential amino acids without the nitrogen waste that a standard high-protein intake would add.
Q2.
In advanced CKD, the kidneys struggle to clear nitrogen waste from protein breakdown, so restricting dietary protein helps reduce this burden — but this risks amino acid deficiency, which ketoanalogues are specifically designed to prevent.
Q3.
Dosing is generally based on body weight, commonly around 1 tablet per 5 kg body weight per day, meaning many adults take 9-14 tablets daily, divided across meals.
Q4.
No, it's a nutritional adjunct used alongside standard CKD management (blood pressure control, other kidney-specific medicines), not a replacement for them.
Q5.
Because it's used with a significant dietary protein restriction, regular monitoring of kidney function, nutritional status, and blood calcium helps ensure the approach remains safe and effective for each individual.
References
Disclaimer
The information on this page is for educational purposes only and is not a substitute for medical advice. Please consult your doctor to know if this treatment is appropriate for your condition.






